Idarucizumab
未知生产厂商
Idarucizumab is an antibody that binds dabigatran for the reversal of anticoagulant effects of dabigatran.
Idarucizumab is an antibody that binds dabigatran for the reversal of anticoagulant effects of dabigatran.
Idarucizumab is a specific reversal agent for dabigatran. It is a humanized monoclonal antibody fragment (Fab) that binds to dabigatran and its acylglucuronide metabolites with higher affinity than the binding affinity of dabigatran to thrombin, neutralizing their anticoagulant effect.
For use in patients treated with Dabigatran when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding.
共 1 项相关疾病